Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             158 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absence of complement component 3 does not prevent classical pathway–mediated hemolysis Zhang, Lingjun

12 p. 1808-1814
artikel
2 A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 Tølbøll Sørensen, Anne Louise

12 p. 2569-2574
artikel
3 A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation Okada, Masahiko

12 p. 2631-2639
artikel
4 A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients Drusbosky, Leylah M.

12 p. 1837-1847
artikel
5 Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2 V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059-1068.
12 p. 2575
artikel
6 Alterations in B- and circulating T-follicular helper cell subsets in immune thrombotic thrombocytopenic purpura Shin, Jin-Sup

12 p. 3792-3802
artikel
7 American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, Sociedad Peruana de Hematología, and SVH 2022 guidelines for prevention of venous thromboembolism in surgical and medical patients and long-distance travelers in Latin America Neumann, Ignacio

12 p. 3636-3649
artikel
8 American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain Brandow, Amanda M.

12 p. 2656-2701
artikel
9 An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Stahl, Maximilian

12 p. 2709-2714
artikel
10 Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin Belcher, Donald A.

12 p. 2739-2750
artikel
11 Approach to the diagnosis of aplastic anemia DeZern, Amy E.

12 p. 2660-2671
artikel
12 A report of clustered COVID-19 in a hematology ward Wu, Yaohui

12 p. 2736-2738
artikel
13 Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia Bosticardo, Marita

12 p. 2611-2616
artikel
14 Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification Etra, Aaron

12 p. 3707-3715
artikel
15 ATG4A regulates human erythroid maturation and mitochondrial clearance Stolla, Massiel Chavez

12 p. 3579-3589
artikel
16 Autologous transplant and second malignancies in MM Pasvolsky, Oren

12 p. 2731-2732
artikel
17 A wholesale approach to disarm multiple myeloma Cenci, Simone

12 p. 2938-2939
artikel
18 B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency Oshrine, Benjamin

12 p. 1795-1798
artikel
19 BCR-ABL + acute myeloid leukemia: are we always dealing with a high-risk disease? Neuendorff, Nina Rosa

12 p. 1409-1411
artikel
20 BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia Olesinski, Elyse A.

12 p. 2917-2923
artikel
21 Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival Gangat, Naseema

12 p. 2694-2698
artikel
22 Blood group ABO gene–encoded A transferase catalyzes the biosynthesis of FORS1 antigen of FORS system upon Met69Thr/Ser substitution Cid, Emili

12 p. 1371-1381
artikel
23 BRAF-V600E–mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor Mastropolo, Rosemarie

12 p. 1848-1853
artikel
24 BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib Bonfiglio, Silvia

12 p. 2794-2806
artikel
25 CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages Haabeth, Ole Audun W.

12 p. 2595-2605
artikel
26 CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells Ansari, Unain

12 p. 3626-3631
artikel
27 Cell origin–dependent cooperativity of mutant Dnmt3a and Npm1 in clonal hematopoiesis and myeloid malignancy SanMiguel, Jennifer M.

12 p. 3666-3677
artikel
28 Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita Shukla, Siddharth

12 p. 2717-2722
artikel
29 Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL Kadri, Sabah

12 p. 715-727
artikel
30 CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia Akahoshi, Yu

12 p. 2699-2708
artikel
31 Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance Clay-Gilmour, Alyssa I.

12 p. 2789-2797
artikel
32 Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function Leung, Isabel

12 p. 2718-2730
artikel
33 Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern Li, Maggie

12 p. 3678-3683
artikel
34 Cotargeting BCL-2 and MCL-1 in high-risk B-ALL Moujalled, Donia M.

12 p. 2762-2767
artikel
35 COVID-19 coagulopathy vs disseminated intravascular coagulation Levi, Marcel

12 p. 2850
artikel
36 CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK+ lymphoma after transplantation Rajan, Soumya Sundara

12 p. 1788-1794
artikel
37 Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis Caron, François

12 p. 772-778
artikel
38 CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study O'Dwyer, M.

12 p. 1815-1825
artikel
39 Defenestrated endothelium delays liver-directed gene transfer in hemophilia A mice Kaminski, Tomasz W.

12 p. 3729-3734
artikel
40 Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment Hill, Quentin A.

12 p. 1897-1906
artikel
41 Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study Stojkov, Igor

12 p. 2772-2783
artikel
42 Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency Bifsha, Panojot

12 p. 2606-2610
artikel
43 Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma Spaan, Ingrid

12 p. 2593-2607
artikel
44 Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice Xiao, Pingnan

12 p. 1480-1494
artikel
45 Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects Li, Shirong

12 p. 2926-2937
artikel
46 Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma Takiar, Radhika

12 p. 2912-2916
artikel
47 Editorial Board
12 p. i
artikel
48 Editorial Board
12 p. i
artikel
49 Editorial Board
12 p. i
artikel
50 Editorial Board
12 p. i
artikel
51 Editorial Board
12 p. i
artikel
52 Editorial Board
12 p. i
artikel
53 Editorial Board
12 p. i
artikel
54 Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma Roddie, Claire

12 p. 2872-2883
artikel
55 External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation Shouval, Roni

12 p. 1881-1890
artikel
56 Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms Spinner, Michael A.

12 p. 2768-2778
artikel
57 Fabrizio VA, Boelens JJ, Mauguen A, et al. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022;6(7):1961-1968.
12 p. 2924
artikel
58 Fertility testing knowledge and attitudes in male adolescents and young adults with SCD and their caregivers: a pilot study Nahata, Leena

12 p. 3703-3706
artikel
59 First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis Vener, Claudia

12 p. 2723-2735
artikel
60 Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders Gadoury-Levesque, Vanessa

12 p. 2578-2594
artikel
61 Front Matter
12 p. ii
artikel
62 Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder Niaz, Aram

12 p. 3779-3791
artikel
63 Further analysis of incidence of multiple myeloma among atomic-bomb survivors, 1950 to 1994 Yoshida, Noriaki

12 p. 2807-2810
artikel
64 Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101 Ritchie, Ellen K.

12 p. 3812-3820
artikel
65 Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes Olin, Rebecca L.

12 p. 2810-2820
artikel
66 Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A Tarrant, Julie

12 p. 2644-2655
artikel
67 Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning van Besien, Koen

12 p. 1858-1867
artikel
68 HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia Lai, Tzung-Huei

12 p. 2897-2911
artikel
69 High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia Durot, Eric

12 p. 3655-3658
artikel
70 HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL McNerney, Kevin O.

12 p. 2758-2771
artikel
71 Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia Renou, Laurent

12 p. 733-747
artikel
72 HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh Chandrakasan, Shanmuganathan

12 p. 3751-3755
artikel
73 Hurdles in treating Hurler disease: potential routes to achieve a “real” cure van den Broek, Brigitte T.A.

12 p. 2837-2849
artikel
74 IFNγ regulates NAD+ metabolism to promote the respiratory burst in human monocytes McCann, Katelyn J.

12 p. 3821-3834
artikel
75 Ilett EE, Jørgensen M, Noguera-Julian M, et al. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv. 2020;4(22):5797-5809.
12 p. 2677
artikel
76 IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML Perriello, Vincenzo Maria

12 p. 2855-2871
artikel
77 Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis Ragon, Brittany Knick

12 p. 2746-2757
artikel
78 Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations Shimonishi, Naruto

12 p. 2831-2842
artikel
79 Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014 Carpenter, Shannon L.

12 p. 1403-1408
artikel
80 Inflammasome activation promotes venous thrombosis through pyroptosis Zhang, Yan

12 p. 2619-2623
artikel
81 Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia Chartomatsidou, Elisavet

12 p. 1891-1896
artikel
82 Interaction between maternal killer immunoglobulin-like receptors and offspring HLAs and susceptibility of childhood ALL Feng, Qianxi

12 p. 3756-3766
artikel
83 Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma Nath, Karthik

12 p. 2644-2649
artikel
84 In vivo dynamics of human hematopoietic stem cells: novel concepts and future directions Scala, Serena

12 p. 1916-1924
artikel
85 KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure Armand, Philippe

12 p. 2617-2622
artikel
86 Koh J, Jang I, Mun S, et al. Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Adv. 2021;5(20):3919-3930.
12 p. 3659-3660
artikel
87 Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.
12 p. 2925
artikel
88 Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis Kalot, Mohamad A.

12 p. 3735-3745
artikel
89 Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice Ingoglia, Giada

12 p. 2751-2761
artikel
90 Lissitchkov T, Willemze A, Katragadda S, et al. Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study. Blood Adv. 2022;6(4):1089-1094.
12 p. 3625
artikel
91 Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis Laroche, Audree

12 p. 3697-3702
artikel
92 Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies Coutre, Steven E.

12 p. 1799-1807
artikel
93 Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients Vulliamy, Paul

12 p. 2623-2630
artikel
94 Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation Li, Ang

12 p. 707-714
artikel
95 Managing patients who are receiving warfarin or a direct oral anticoagulant and need an elective surgery or procedure Douketis, James

12 p. 1925
artikel
96 Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage Uter, Stacey

12 p. 2586-2592
artikel
97 Metformin for treatment of cytopenias in children and young adults with Fanconi anemia Pollard, Jessica A.

12 p. 3803-3811
artikel
98 More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura Picod, Adrien

12 p. 2678-2680
artikel
99 MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods Roshal, Mikhail

12 p. 728-732
artikel
100 Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review Rhee, John Y.

12 p. 1854-1857
artikel
101 NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation Hogan, Louise E.

12 p. 1412-1416
artikel
102 Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission Rashidi, Armin

12 p. 1826-1836
artikel
103 Papaioannou D, Volinia S, Nicolet D, et al. Clinical and functional significance of circular RNAs in cytogenetically normal AML. Blood Adv. 2020;4(2):239-251.
12 p. 2577
artikel
104 PD-1 blockade enhances elotuzumab efficacy in mouse tumor models Bezman, Natalie A.

12 p. 753-765
artikel
105 Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL Zurko, Joanna

12 p. 2657-2669
artikel
106 Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism Yepes-Nuñez, Juan José

12 p. 2798-2809
artikel
107 Physiologically based serum ferritin thresholds for iron deficiency in women of reproductive age who are blood donors Addo, O. Yaw

12 p. 3661-3665
artikel
108 Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy Lee, Brittany M.

12 p. 2825-2830
artikel
109 Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells Puhm, Florian

12 p. 3593-3605
artikel
110 Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice Fan, Xuemei

12 p. 1439-1448
artikel
111 Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor Politikos, Ioannis

12 p. 1367-1370
artikel
112 Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant Al Malki, Monzr M.

12 p. 2650-2659
artikel
113 Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data Parviz, Mehdi

12 p. 3716-3728
artikel
114 Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method Vachon, Celine M.

12 p. 3746-3750
artikel
115 Prevalence of IGLV3-21R110 among familial CLL: a retrospective study of 45 cases Armand, Marine

12 p. 3632-3635
artikel
116 Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy Vick, Eric J.

12 p. 779-791
artikel
117 Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets Casari, Caterina

12 p. 1417-1428
artikel
118 Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations Andolfo, Immacolata

12 p. 2681-2693
artikel
119 Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.
12 p. 2576
artikel
120 Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α Macchi, Beatrice

12 p. 748-752
artikel
121 Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma Peres, Lauren C.

12 p. 3767-3778
artikel
122 Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma Iacoboni, Gloria

12 p. 3606-3610
artikel
123 Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome Katzerke, Christiane

12 p. 2811-2824
artikel
124 Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001 Vrooman, Lynda M.

12 p. 1449-1458
artikel
125 Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment Darzi, Andrea J.

12 p. 2557-2566
artikel
126 Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report Johnston, Emily E.

12 p. 2843-2854
artikel
127 Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling Wu, Vernon

12 p. 1470-1479
artikel
128 Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study Ageno, Walter

12 p. 3569-3578
artikel
129 Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation Petersdorf, Effie W.

12 p. 2888-2896
artikel
130 Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice Neunert, Cindy E.

12 p. 1907-1915
artikel
131 Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency Wu, Zhijie

12 p. 2702-2716
artikel
132 Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma Allen, Pamela B.

12 p. 2670-2676
artikel
133 Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes Ali, Abdullah Mahmood

12 p. 1393-1402
artikel
134 Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden Karantanos, Theodoros

12 p. 2567-2576
artikel
135 Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma Gardner, Andrea

12 p. 3650-3654
artikel
136 Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL Wölfl, Matthias

12 p. 1382-1385
artikel
137 Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis Patel, Payal

12 p. 2779-2788
artikel
138 The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia Kumar, Rahul

12 p. 3611-3624
artikel
139 The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective George, James N.

12 p. 1510-1516
artikel
140 The use of defibrotide in blood and marrow transplantation Richardson, Paul G.

12 p. 1495-1509
artikel
141 TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation Shrimpton, Jennifer

12 p. 2821-2836
artikel
142 Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma Dahi, Parastoo B.

12 p. 2608-2618
artikel
143 Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression Manson, Megan A.

12 p. 3557-3568
artikel
144 161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS Sarhan, Dhifaf

12 p. 1459-1469
artikel
145 TTMV-RARA fusion as a recurrent cause of AML with APL characteristics Sala-Torra, Olga

12 p. 3590-3592
artikel
146 Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate Zannoni, Johanna

12 p. 1868-1880
artikel
147 Unraveling the pathophysiology of lower-limb postthrombotic syndrome in adolescents: a proof-of-concept study Avila, M. Laura

12 p. 2784-2793
artikel
148 Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse Berdel, Andrew F.

12 p. 3684-3696
artikel
149 Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993.
12 p. 2715-2717
artikel
150 Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients Vijenthira, Abi

12 p. 2624-2643
artikel
151 Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID) Drott, Kristina

12 p. 1386-1392
artikel
152 Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation Zhang, Shijia

12 p. 2640-2643
artikel
153 Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells Teh, Charis E.

12 p. 2733-2745
artikel
154 Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis Yamshon, Samuel

12 p. 1429-1438
artikel
155 Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome Sun, Chunyan

12 p. 2563-2568
artikel
156 X-ray crystal structure of plasmin with tranexamic acid–derived active site inhibitors Law, Ruby H.P.

12 p. 766-771
artikel
157 Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma Tam, Constantine S.

12 p. 2577-2585
artikel
158 Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia Tam, Constantine S.

12 p. 2884-2887
artikel
                             158 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland